Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Invitae Corp (NY: NVTA )

27.10 USD -0.51 (-1.85%)
Official Closing Price Updated: 4:10 PM EDT, Jul 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,802,310
Open 27.60
Bid (Size) 26.93 (5)
Ask (Size) 27.20 (1)
Prev. Close 27.61
Today's Range 26.02 - 27.75
52wk Range 25.24 - 61.59
Shares Outstanding 199,837,259
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Volpara Collaborates With Invitae Corporation, Leading Genetics Company
Collaboration Expands Access to Genetic Testing and Risk Assessment Capabilities Available through Volpara's Breast Health Platform 
From PR Newswire
Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2021 financial results on Tuesday, August 3, 2021 and will host a conference... 
From PR Newswire

Performance

YTD
-37.90%
-37.90%
1 Month
-21.38%
-21.38%
3 Month
-28.48%
-28.48%
6 Month
-48.11%
-48.11%
1 Year
-14.19%
-14.19%

More News

Read More
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
From GlobeNewswire News Releases
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
From GlobeNewswire News Releases
Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
From PR Newswire
Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors
From Business Wire News Releases
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
Tags NVTA Health Care PACB
From Benzinga
Peek Under The Hood: WDNA Has 33% Upside
Tags ETFs
From ETF Channel
Noteworthy Monday Option Activity: FE, ROIC, NVTA
Tags Stocks
From Market News Video
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
Tags BNGO NVTA PFE
From Motley Fool
Analyzing Invitae's Unusual Options Activity
Tags Options Markets Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.